Table Of Contents
1. Market Context & Strategic Relevance
1.1 Opening Context (Why the market matters)
1.1.1 Why This Market Is Gaining Strategic Attention
1.1.2 Business Decisions This Report Supports
1.2 Scope
1.3 Research & Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Type
2.3.2 Market Size By Source of Service
2.3.3 Market Size By Application
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO's Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter's) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1. Component & Subsystem Suppliers
3.4.2. Medical Second Opinion Service Providers
3.4.3. Distributors & Channel Partners
3.4.4. End Users
3.5 Industry Life Cycle Assessment
4. Statistical Insights & Trends Reporting
4.1 Consultation Volume & Throughput Metrics
4.1.1 North America Medical Second Opinion Consultation Volumes
4.1.2 Average Second Opinion Cases Processed per Provider Annually
4.1.3 Case Review Accuracy & Diagnostic Concordance Benchmarks
4.1.4 Patient Intake-to-Opinion Delivery Turnaround Efficiency
4.2 Application & Clinical Outcome Statistics
4.2.1 Cancer & Cardiac Disorder Second Opinion Volumes
4.2.2 Neurological & Orthopaedic Disorder Consultation Statistics
4.2.3 Diabetes & Respiratory Disorder Second Opinion Volumes
4.2.4 Treatment Plan Modification Rate Following Second Opinion
4.3 Service, Resource & Operating Economics
4.3.1 Medical Second Opinion Provider Installed Capacity
4.3.2 Physician Network Utilization & Case Capacity
4.3.3 Administrative & Technology Resource Consumption per Case
4.3.4 Average Cost per Medical Second Opinion Consultation
4.4 Workflow & Service Metrics
4.4.1 Automated vs. Manual Case Review Workflow Penetration
4.4.2 In-House vs. Outsourced Second Opinion Service Activity
4.4.3 Case Submission-to-Result Turnaround Benchmarks
4.4.4 Service Order & Repeat-Usage Metrics
4.5 Technology, Quality & Innovation Indicators
4.5.1 Diagnostic Accuracy & Quality Score Benchmarks
4.5.2 Telehealth & Digital Platform Performance Metrics
4.5.3 Digital Monitoring & Software Integration Penetration
4.5.4 Product Launch, Patent & Technology Development Activity
5. North America Medical Second Opinion Market Segmental Analysis & Forecast, By Type, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 Hospital Physicians/Specialties
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2035
5.3 Online Physicians Portals
5.4 Medical Second Opinion Companies
5.5 Health Insurance Companies
6. North America Medical Second Opinion Market Segmental Analysis & Forecast, By Source of Service, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 Outsourced
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 In-House
7. North America Medical Second Opinion Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Cancer
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Cardiac Disorders
7.4 Neurological Disorders
7.5 Diabetes
7.6 Respiratory Disorders
7.7 Orthopaedic Disorders
7.8 Others
8. North America Medical Second Opinion Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 US
8.2.1 Key Trends
8.2.2 North America Medical Second Opinion Market Size & Forecast, By Type, 2022–2035
8.2.3 North America Medical Second Opinion Market Size & Forecast, By Source of Service, 2022–2035
8.2.4 North America Medical Second Opinion Market Size & Forecast, By Application, 2022–2035
8.3 Canada
8.3.1 Key Trends
8.3.2 North America Medical Second Opinion Market Size & Forecast, By Type, 2022–2035
8.3.3 North America Medical Second Opinion Market Size & Forecast, By Source of Service, 2022–2035
8.3.4 North America Medical Second Opinion Market Size & Forecast, By Application, 2022–2035
9. Competitive Landscape
9.1 Key Players' Positioning
9.2 Competitive Developments
9.2.1 Year-Wise Strategies & Development, 2022–2026
9.3 Market Share Analysis, 2025
9.4 Product/Service & Application Benchmarking
9.4.1 Product/Service Specifications & Features By Key Players
9.4.2 Product/Service Heatmap By Key Players
9.4.3 Application Heatmap By Key Players
9.5 Industry Start-Up & Innovation Landscape
9.6 Key Company Profiles
9.6.1 Teladoc Health
9.6.1.1 Company Overview & Snapshot
9.6.1.2 Product/Service Portfolio
9.6.1.3 Key Company Financials
9.6.1.4 Geographical Presence
9.6.1.5 SWOT Analysis
9.6.2 Included Health
9.6.3 2nd.MD
9.6.4 Cleveland Clinic
9.6.5 Mayo Clinic
9.6.6 Johns Hopkins Medicine International
9.6.7 Cigna Healthcare
9.6.8 Optum
9.6.9 HCA Healthcare
9.6.10 MDLIVE
9.6.11 WorldCare International
9.6.12 AXA Health
9.6.13 PinnacleCare International
9.6.14 Alight Solutions
9.6.15 MORE Health
9.6.16 Sun Life Health Navigator
9.6.17 Accolade
9.6.18 Medisense Healthcare Solutions
9.6.19 Global Second Opinion
9.6.20 Second Opinion International
10. Analyst Recommendations
10.1 SNS Insider Opportunity Map
10.2 Industry Low-Hanging Fruit Assessment
10.3 Market Entry & Growth Strategy
10.4 Analyst Viewpoint & Suggestions On Market Growth
11. Assumptions
12. Disclaimer
13. Appendix
13.1 List Of Tables
13.2 List Of Figures
Frequently Asked Questions
Key players include Teladoc Health, Included Health, 2nd.MD, Cleveland Clinic, Mayo Clinic, Johns Hopkins Medicine International, Cigna Healthcare, Optum, HCA Healthcare and MDLIVE, among others.
Key opportunities include growing Canadian private-insurance coverage expansion and continued growth of AI-enabled case triage and specialist-matching technology.
The market is driven by growing employer-sponsored benefit adoption, sustained oncology and cardiac review volumes, and rising insurer utilization-management demand across the United States and Canada.
The Hospital Physicians/Specialties segment dominates the North America Medical Second Opinion Market, accounting for approximately 40.85% share in 2025.
The U.S. dominated the North America Medical Second Opinion Market in 2025 with approximately 82.35% share, driven by a deep base of leading academic medical centers and employer-sponsored benefit programs.